Teleflex (TFX)
(Delayed Data from NYSE)
$220.30 USD
-2.19 (-0.98%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $220.29 -0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Brokerage Reports
Teleflex Incorporated [TFX]
Reports for Purchase
Showing records 421 - 440 ( 474 total )
Company: Teleflex Incorporated
Industry: Medical - Instruments
Medical Technology: 4Q Preview; No Real Changes to Outlooks; Reducing Estimates Again for FX
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Larger - More Expensive, but Consistent with Strategy of Acquiring Sales Growth - Gross Margin Accretive Targets
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Industry: Takeaways from AAGL
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Growth and Margin Expectations Appear More Muted NT; Lowering Estimates
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Reduced Sales Guidance and Changes to Restructuring Actions Likely to Offset EPS Positives
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Benefits of Gross Margin Initiatives Evident and Driving EPS Leverage
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Similar to Peers, Solid Quarter and Modest Bump to EPS Guidance
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Valuation Still Matters; Downgrade to SW
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Raising Estimates and PT, but Still See Incremental Upside to our Model
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Results a Modest Positive, but Expectations Were Raised Given Competitive Reports
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Industry: Takeaways from SAGES Meetings; Incrementally Positive on TFX - HRC
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Organic Growth and Margin Trajectory Strengthening into 2016; Raise PT to $159
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Industry: 4Q Earnings Preview; Results Likely in Line; Cautious Around 2016 Guidance
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
2016 KBCM Healthcare Outlook
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Research Summary
Provider: KEYBANC CAPITAL MARKETS